Nanoparticles for Fidgety Cell Movement and Enhanced Wound Healing

Abstract

Complex spatiotemporal interaction of Rho GTPases with microtubules (MTs) and MT-associated proteins drives directed cellular migration. In this issue, Charafeddine et al. describe a role for a novel MT-severing enzyme, fidgetin-like 2 (FL2), in directional migration of keratinocytes and fibroblasts. FL2 normally localizes to the leading edge of the cell cortex where it shears MTs, thus dictating the size and distribution of focal adhesions by regulating cytoskeletal remodeling. Small interfering RNA (siRNA)-directed knockdown of FL2 increases cell migration and focal adhesion area in vitro through possible interaction with Rho GTPases. Efficient FL2 knockdown in murine wounds was achieved using nanoparticles as a siRNA delivery vehicle, and this resulted in enhanced wound closure in vivo. Effective siRNA nanoparticle targeting of MT-severing enzymes offers promise of controlled and targeted delivery that may maximize therapeutic success for patients with burn wounds and chronic wound disorders.

Nanoparticle-Based Therapeutic Approach for Diabetic Wound Healing

“…In vivo delivery of siRNA requires a carrier for transport into cells to protect against physiological nucleases. Nanoparticle-based technology has enabled targeted transport of siRNA and prevention from degradation [ 92 , 93 ]. Clinical studies delivering siRNA to cure several diseases have been promising, yet primary clinical trials were unsuccessful due to inadequate efficacy or significant off-target effects.…”

Nanoparticles in wound healing from hope to promise from promise to routine

“…Another way to facilitate wound closure apart from inducing angiogenesis is to minimise local motility in the cellular level. Fidgeting-like 2 is a severin enzyme involved in this process, and inhibition with target delivery of siRNA using nanoparticles accelerates healing (4,136). Intradermal delivery of key genes such as the sonic hedgehog has been performed, as well.…”

Viability and proliferation of endothelial cells upon exposure to GaN nanoparticles

“…Based on biological examples, new and innovative biological materials can be designed through self-organization or direct structuring. Focusing on the methods involving biointerfaces and the connection between technology and cells, further developments are being made in bioactive material targets, regeneration of natural tissue [2], and the acceleration or delay of biological or biochemical processes [3]. Nanoparticle-based systems are the best choice for biomedical applications not only due to their small size (from 1 to 100 nm), but also due to their potency, which results from their high surface area for active molecules.…”